3

PRIMARY DOCUMENT

Company: LEXICON PHARMACEUTICALS, INC.
Filed: March 25, 2011
Period of Report: March 23, 2011
Accession Number: 0001127602-11-011216

View Document ↗ View on SEC.gov ↗